Microbix Biosystems Inc.
focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers.
Microbix has signed a letter of intent to finance the development of the Company’s LumiSort®
prototype instrument, and has engaged Lathrop Engineering of California to design, build, and test the prototype. LumiSort(R)
is a livestock sex-selection technology, which has already been verified by Lathrop, and has received patent protection from European Patent offices.
Read more developments in the Perspective here: Microbix Biosystems eResearch
is a primary source for professional investment research, focused on small- and mid-cap companies. Our research and analysis is of institutional quality, and has the potential for reaching millions of global investors through our extensive electronic distribution network. eResearch
posts all its reports and articles on its website, eresearch.ca
, and subscription is FREE.
eResearch: Bob Weir, CFA, Director of Research